Benefits of adjunctive N-acetylcysteine in a sub-group of clozapine-treated individuals diagnosed with schizophrenia
Version 2 2024-06-02, 13:29Version 2 2024-06-02, 13:29
Version 1 2016-01-04, 09:23Version 1 2016-01-04, 09:23
journal contribution
posted on 2024-06-02, 13:29 authored by Olivia DeanOlivia Dean, SG Mancuso, AI Bush, D Copolov, KQ Do, M Cuénod, P Conus, SL Rossell, DJ Castle, Michael BerkMichael BerkBenefits of adjunctive N-acetylcysteine in a sub-group of clozapine-treated individuals diagnosed with schizophrenia
History
Journal
Psychiatry researchVolume
230Pagination
982-983Location
Amsterdam, The NetherlandsPublisher DOI
ISSN
0165-1781eISSN
1872-7123Language
engPublication classification
C4 Letter or noteCopyright notice
2016, ElsevierIssue
3Publisher
ElsevierPublication URL
Usage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicinePsychiatryDOUBLE-BLINDInnovation in Mental and Physical Health and Clinical Treatment920112 Neurodegenerative Disorders Related to Ageing110999 Neurosciences not elsewhere classified110319 Psychiatry (incl Psychotherapy)School of MedicineFaculty of Health920410 Mental Health420313 Mental health services200409 Mental health
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC